生产企业：Beeline Medicines
Afimetoran is an investigational, selective, oral, once-daily, equipotent small-molecule inhibitor of Toll-like receptors 7 and 8 (TLR7/8), being developed by Beeline Medicines for systemic lupus erythematosus.
Afimetoran is an investigational, selective, oral, once-daily, equipotent small-molecule inhibitor of Toll-like receptors 7 and 8 (TLR7/8), being developed by Beeline Medicines for systemic lupus erythematosus.
Afimetoran acts as an antagonist of TLR 7/8.
共 1 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
未检索到以该名称命名的专利
专利文献通常使用化学名或研发代号指代药物，而非通用名；且专利申请在提交约 18 个月后才公开，较新的药物可能尚未出现在这里。
